Author(s):
Shinde Siddhi Suhas, Anuradha Prajapati, Sachin B. Narkhede, Shailesh Luhar
Email(s):
anuradha@ssgsalvav.in
DOI:
10.52711/0975-4377.2025.00006 
Address:
Shinde Siddhi Suhas1*, Anuradha Prajapati2, Sachin B. Narkhede2, Shailesh Luhar2
1Smt. B.N.B Swaminarayan Pharmacy College, Salvav - Vapi, Gujarat.
2Department of Pharmaceutics, Smt. BNB Swaminarayan Pharmacy College, Gujarat Technological University, Salvav, Vapi, Gujarat, India, 396191.
*Corresponding Author
Published In:
Volume - 17,
Issue - 1,
Year - 2025
ABSTRACT:
This comprehensive review aims to alert and educate physicians, pharmacists, healthcare professionals, and the general public to the emerging threat of Primary amoebic meningoencephalitis (PAM) that is a rare but potentially fatal neurological disease caused by the free-living amoeba Naegleria fowleri. Thermophilic amoeba Naegleria fowleri is a serious hazard to human health. Swimming in freshwater bodies or rinsing one's nose with contaminated water may lead to exposure to N. fowleri-infected water, which can cause primary amoebic meningoencephalitis. PAM causes total brain tissue damage, which puts the patient in a coma and ultimately results in death. An extensive summary of the biology, epidemiology, symptoms, diagnosis, and available treatments for N. fowleri is given in this review article.
Cite this article:
Shinde Siddhi Suhas, Anuradha Prajapati, Sachin B. Narkhede, Shailesh Luhar. Naegleria fowleri: An Amoeba That Eats your Brain. Research Journal of Pharmaceutical Dosage Forms and Technology. 2025; 17(1):37-0. doi: 10.52711/0975-4377.2025.00006
Cite(Electronic):
Shinde Siddhi Suhas, Anuradha Prajapati, Sachin B. Narkhede, Shailesh Luhar. Naegleria fowleri: An Amoeba That Eats your Brain. Research Journal of Pharmaceutical Dosage Forms and Technology. 2025; 17(1):37-0. doi: 10.52711/0975-4377.2025.00006 Available on: https://rjpdft.com/AbstractView.aspx?PID=2025-17-1-6
REFERENCES:
1. Ahmad Zamzuri, M.‘A.I.; Abd Majid, F.N.; Mihat, M.; Ibrahim, S.S.; Ismail, M.; Abd Aziz, S.; Mohamed, Z.; Rejali, L.; Yahaya, H.; Abdullah, Z.; et al. Systematic Review of Brain-Eating Amoeba: A Decade Update. Int. J. Environ. Res. Public Health 2023; 20: 3021. https://doi.org/10.3390/ijerph20043021n
2. Borkens, Y. The Pathology of the Brain Eating Amoeba Naegleria fowleri. Indian J Microbiol. 2024; 64: 1384–1394. https://doi.org/10.1007/s12088-024-01218-5
3. Marciano-Cabral F. Biology of Naegleria spp. Microbiol Rev. 1988 Mar; 52(1): 114-33. doi: 10.1128/mr.52.1.114-133.1988. PMID: 3280964; PMCID: PMC372708.
4. Ismail N, Yusof H. Occurance of the pathogenic Amoeba Naegleria fowleri, pathogenesis, diagnosis, and treatment options. Mal J Med Health Sci. 2021; 17(4): 285-295
5. Grace E, Asbill S, Virga K. Naegleria fowleri: pathogenesis, diagnosis, and treatment options. Antimicrob Agents Chemother. 2015 Nov; 59(11): 6677-81. doi: 10.1128/AAC.01293-15. Epub 2015 Aug 10. PMID: 26259797; PMCID: PMC4604384.
6. Alli A, Ortiz JF, Morillo Cox Á, Armas M, Orellana VA. Miltefosine: A Miracle Drug for Meningoencephalitis Caused by Free-Living Amoebas. Cureus. 2021 Mar 4; 13(3): e13698. doi: 10.7759/cureus.13698. PMID: 33833918; PMCID: PMC8020194.
7. Ruqaiyyah Siddiqui, David Lloyd, Ahmad M. Alharbi and Naveed Ahmed Khan. Emerging therapies against Naegleria fowleri, Expert Opinion on Orphan Drugs. 2024; 12(1): 41-49, DOI: 10.1080/21678707.2024.2383173
8. Pervin N, Sundareshan V. Naegleria. [Updated 2022 Sep 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK535447/
9. Chen, M.; Ruan, W.; Zhang, L.; Hu, B.; Yang, X. Primary amebic meningoencephalitis: A case report. Korean J. Parasitol. 2019; 57: 291–294.
10. Ravinder, K.; Uppal, B.; Aggarwal, P.; Mehra, B.; Hasan, F.; Mridul Daga, K. Co-infection of central nervous system by M. Tuberculosis, Cryptococcus and possibly Naegleria fowleri. Trop. Biomed. 2016; 33: 387–392
11. Cope, J.R.; Murphy, J.; Kahler, A.; Gorbett, D.G.; Ali, I.; Taylor, B.; Corbitt, L.; Roy, S.; Lee, N.; Roellig, D.; et al. Primary Amebic Meningoencephalitis Associated with Rafting on an Artificial Whitewater River: Case Report and Environmental Investigation. Clin. Infect. Dis. 2018; 66: 548–553.
12. Yadav, D.; Aneja, S.; Dutta, R.; Maheshwari, A.; Seth, A. Youngest survivor of Naegleria meningitis. Indian J. Pediatr. 2013; 80: 253–254.
13. Dunn, A.L.; Reed, T.; Stewart, C.; Levy, R.A. Naegleria fowleri that induces primary amoebic meningoencephalitis: Rapid diagnosis and rare case of survival in a 12-year-old Caucasian girl. Lab. Med. 2016; 47: 149–154.
14. Senthil kumar K, Manoj Varma G, Vudaykiran A, R Arun Kumar and B Sudhakar. Nasal Drug Delivery System - An Overview. International Journal of Pharmaceutical and Chemical Sciences. 2012; 1(3): 1358-1367.
15. Muhammad U. Ghori, Mohammed H. Mahdi, Alan M. Smith, Barbara R. Conway. Nasal Drug Delivery Systems: An Overview. American Journal of Pharmacological Sciences. 2015; 3: 110.
16. Article on Nasal drug delivery: An approach of drug delivery through nasal route by Sanjay Dey, Beduin Mahanti, Bhaskar Mazumder, Ananaya Malgope, Sandeepan Desgupata. Published by Pelagia Research Library. 2014; 1.
17. Pagar Swati Appasaheb, Shinkar Dattatraya Manohar, Saudagar Ravindra Bhanudas. A Review on Intranasal Drug Delivery System. Journal of Advanced Pharmacy Education and Research. 2013; 3(4): 334-340.
18. Prajapati M., Mandloi R., Pillai S, Birla N. The Review on The Nasal Drug Delivery. Asian J. Pharm. Res. 2020; 10(2):110-116. doi: 10.5958/2231-5691.2020.00021.0